# Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia

> **NCT01119586** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 350 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **GENETIC:** DNA analysis
- **GENETIC:** genetic linkage analysis
- **GENETIC:** microarray analysis
- **GENETIC:** nucleic acid sequencing
- **GENETIC:** polymerase chain reaction
- **GENETIC:** polymorphism analysis
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01119586
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2016-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01119586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01119586, "Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01119586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*